Delivery Order SPE2DB20D3505-SPE2DB22FT3B2
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order valued at $4,660.60 issued by the Defense Logistics Agency (DLA) for the procurement of Varenicline 1 mg tablets. The contract has a completion date of February 8, 2024 and is a Firm Fixed Price type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,767.17 delivery order contract is for the supply of APO-VARENICLINE 1 MG TABLET 56S, a pharmaceutical product. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,001.64 firm-fixed-price delivery order is for the supply of 56 counts of 1 mg Varenicline tablets. The contract has an ultimate completion date of May 11, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) worth $5,415.11 for the supply of pharmaceutical products, including Varenicline, to support the Department of Defense (DoD) and military healthcare programs. The contract, which has an ultimate completion date of October 17, 2023, was awarded on October 16, 2023 by the Defense Logistics Agency (DLA) Troop Support Medical, a major contracting agency for the DoD. Amerisourcebergen...
- This federal contract award, valued at $2,944.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of APO-VARENICLINE 0.5 MG TABLET 56S, a prescription medication, with a completion date of May 22, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Cencora, Inc. holds a significant...
- This contract award is for the delivery of Varenicline 1 mg tablets (56 count bottles) to the Defense Logistics Agency (DLA). The $3,297.82 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of Varenicline 1 mg tablets. The $4,444.74 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,180.98 fixed-price delivery order is for the supply of Varenicline 1 mg tablets. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract valued at $1,673.82 for the supply of 4,565,031,699 units of the drug varenicline 1 mg tablets. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a wide range of pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $11,233.19 firm fixed-price delivery order contract is for the provision of medical products, including medications such as Varenicline, to support the DLA Troop Support Medical program. The contract has an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT3B2Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $3,469.70 for the supply of APO-VARENICLINE 1 MG TABLET 56S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical care materials, to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 12/7/21 |